United States Gene-Deleted Vaccines Market Report 2016

Publisher Name :
Date: 13-Sep-2016
No. of pages: 124

Notes:

Sales, means the sales volume of Gene-Deleted Vaccines

Revenue, means the sales value of Gene-Deleted Vaccines

This report studies sales (consumption) of Gene-Deleted Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer HealthCare AG (Germany)

- Biogenesis-Bago (Argentina)

- Boehringer Ingelheim GmbH (Germany)

- Ceva Sante Animale (France)

- Heska Corporation (US)

- Indian Immunologicals Ltd (India)

- Lohmann Animal Health (US)

- Merck Animal Health (US)

- Merial Ltd. (US)

- Protein Sciences Corporation (US)

- Virbac SA (France)

- Zoetis Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Gene-Deleted Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Gene-Deleted Vaccines Market Report 2016

Table of Contents
United States Gene-Deleted Vaccines Market Report 2016
1 Gene-Deleted Vaccines Overview
1.1 Product Overview and Scope of Gene-Deleted Vaccines
1.2 Classification of Gene-Deleted Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Gene-Deleted Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Gene-Deleted Vaccines (2011-2021)
1.4.1 USA Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
1.4.2 USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
2 USA Gene-Deleted Vaccines Competition by Manufacturers
2.1 USA Gene-Deleted Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Gene-Deleted Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Gene-Deleted Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Gene-Deleted Vaccines Market Competitive Situation and Trends
2.4.1 Gene-Deleted Vaccines Market Concentration Rate
2.4.2 Gene-Deleted Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Gene-Deleted Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Gene-Deleted Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Gene-Deleted Vaccines Price by Type (2011-2016)
3.4 USA Gene-Deleted Vaccines Sales Growth Rate by Type (2011-2016)
4 USA Gene-Deleted Vaccines Sales (Volume) by Application (2011-2016)
4.1 USA Gene-Deleted Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Gene-Deleted Vaccines Manufacturers Profiles/Analysis
5.1 Bayer HealthCare AG (Germany)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Biogenesis-Bago (Argentina)
5.2.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim GmbH (Germany)
5.3.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Ceva Sante Animale (France)
5.4.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Heska Corporation (US)
5.5.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indian Immunologicals Ltd (India)
5.6.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Lohmann Animal Health (US)
5.7.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Merck Animal Health (US)
5.8.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Merial Ltd. (US)
5.9.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Protein Sciences Corporation (US)
5.10.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Virbac SA (France)
5.12 Zoetis Inc. (US)
6 Gene-Deleted Vaccines Manufacturing Cost Analysis
6.1 Gene-Deleted Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gene-Deleted Vaccines
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Gene-Deleted Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Gene-Deleted Vaccines Market Forecast (2016-2021)
10.1 USA Gene-Deleted Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Gene-Deleted Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Gene-Deleted Vaccines Sales Forecast by Application (2016-2021)
10.4 Gene-Deleted Vaccines Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Gene-Deleted Vaccines
Table Classification of Gene-Deleted Vaccines
Figure USA Sales Market Share of Gene-Deleted Vaccines by Type in 2015
Table Application of Gene-Deleted Vaccines
Figure USA Sales Market Share of Gene-Deleted Vaccines by Application in 2015
Figure USA Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
Figure USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Table USA Gene-Deleted Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Gene-Deleted Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gene-Deleted Vaccines Sales Share by Manufacturers
Figure 2016 Gene-Deleted Vaccines Sales Share by Manufacturers
Table USA Gene-Deleted Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Gene-Deleted Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Gene-Deleted Vaccines Revenue Share by Manufacturers
Table 2016 USA Gene-Deleted Vaccines Revenue Share by Manufacturers
Table USA Market Gene-Deleted Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Gene-Deleted Vaccines Average Price of Key Manufacturers in 2015
Figure Gene-Deleted Vaccines Market Share of Top 3 Manufacturers
Figure Gene-Deleted Vaccines Market Share of Top 5 Manufacturers
Table USA Gene-Deleted Vaccines Sales by Type (2011-2016)
Table USA Gene-Deleted Vaccines Sales Share by Type (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Market Share by Type in 2015
Table USA Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Gene-Deleted Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gene-Deleted Vaccines by Type (2011-2016)
Table USA Gene-Deleted Vaccines Price by Type (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Gene-Deleted Vaccines Sales by Application (2011-2016)
Table USA Gene-Deleted Vaccines Sales Market Share by Application (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Market Share by Application in 2015
Table USA Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene-Deleted Vaccines
Figure Manufacturing Process Analysis of Gene-Deleted Vaccines
Figure Gene-Deleted Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
Table Major Buyers of Gene-Deleted Vaccines
Table Distributors/Traders List
Figure USA Gene-Deleted Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Gene-Deleted Vaccines Production Forecast by Type (2016-2021)
Table USA Gene-Deleted Vaccines Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Global Migranal Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Migranal Revenue, means the sales value of Migranal This report studies Migranal in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Bayer - Marina Biotech - Merck - Sanofi - Novartis AG Market Segme......
  • Global Imitrex Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Imitrex Revenue, means the sales value of Imitrex This report studies Imitrex in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - Bayer - GlaxoSmithKline - Marina Biotech - Merck - Sanofi - O......
  • Global Flonase Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 106
    Notes: Production, means the output of Flonase Revenue, means the sales value of Flonase This report studies Flonase in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Bayer - GlaxoSmithKline - Merck - Sanofi - Bespak Market Segment by R......
  • Global Argatroban Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Argatroban Revenue, means the sales value of Argatroban This report studies Argatroban in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - SANDOZ - GlaxoSmithKline - fresenius-kabi - Eagle Pharmaceuticals......
  • Global Antiandrogen Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Antiandrogen Revenue, means the sales value of Antiandrogen This report studies Antiandrogen in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - Abbott Laboratories - Genentech - GlaxoSmithKline - Immunome......
  • Global Small Molecule Kinase Inhibitor Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 116
    Notes: Production, means the output of Small Molecule Kinase Inhibitor Revenue, means the sales value of Small Molecule Kinase Inhibitor This report studies Small Molecule Kinase Inhibitor in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Bristol-Myers Squibb - Amgen Inc.......
  • Global H7N9 Vaccine Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 104
    Notes: Production, means the output of H7N9 Vaccine Revenue, means the sales value of H7N9 Vaccine This report studies H7N9 Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Beijing Tiantan Biological Products - Hualan Bio - Sinovac Market Se......
  • Global Ketorolac Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 103
    Notes: Production, means the output of Ketorolac Revenue, means the sales value of Ketorolac This report studies Ketorolac in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - PubMed Health - Cayman Chemical Market Segment by Regions, this report splits Global......
  • Global Polio Vaccines Market Research Report 2017
    Published: 17-Feb-2017        Price: US 2900 Onwards        Pages: 104
    Notes: Production, means the output of Polio Vaccines Revenue, means the sales value of Polio Vaccines This report studies Polio Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Astellas Pharma - CSL - Emergent BioSolutions - GlaxoSmithKline ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs